Join
Live feed
·
INSIDERFilingvia Quantisnow
Poseida Therapeutics Inc. logo

SEC Form 4: Malin Life Sciences Holdings Ltd bought $7,525,000 worth of shares (2,150,000 units at $3.50), increasing direct ownership by 22% to 11,835,673 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PSTX (Poseida Therapeutics Inc.) and more on Quantisnow.

SEC Form 4: Malin Life Sciences Holdings Ltd bought $7,525,000 worth of shares (2,150,000 units at $3.50), increasing direct ownership by 22% to 11,835,673 units | Quantisnow